Drugs / Enoxolone
Enoxolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05570110 | Sep 2022 → Jun 2026 overdue | major depressive disorder | Philipps University Marburg | Recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enoxolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05570110 ↗ |
| Known as | Enoxolona | ChEMBL registry synonym — accepted as the source's own label CHEMBL230006 ↗ |
| Known as | NSC-35347 | ChEMBL registry synonym — accepted as the source's own label CHEMBL230006 ↗ |
| Known as | NSC-35350 | ChEMBL registry synonym — accepted as the source's own label CHEMBL230006 ↗ |
| Action | Inhibit | “11-beta hydroxysteroid-dehydrogenase type 2 (11betaHSD2) and toll-like receptor (TLR)-4 inhibitor enoxolone” NCT05570110 ↗ |
| Modality | Small molecule | — CHEMBL230006 ↗ |